Neurogene
NGNE
NGNE
85 hedge funds and large institutions have $187M invested in Neurogene in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 26 increasing their positions, 28 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
7% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 28
25% less capital invested
Capital invested by funds: $249M → $187M (-$61.5M)
Holders
85
Holding in Top 10
–
Calls
$287K
Puts
$87K
Top Buyers
| 1 | +$2.5M | |
| 2 | +$1.31M | |
| 3 | +$886K | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$845K |
| 5 |
Two Sigma Advisers
New York
|
+$830K |
Top Sellers
| 1 | -$10.8M | |
| 2 | -$4.52M | |
| 3 | -$2.98M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$787K |
| 5 |
Goldman Sachs
New York
|
-$658K |